MENU
AVIR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Atea Pharmaceuticals (AVIR) Earnings Date & Reports
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
AVIR is expected to report earnings to rise 32.93% to -54 cents per share on November 05
Q3'26
Est.
$-0.55
Q2'26
Beat
by $0.15
Q1'26
Missed
by $0.01
Q4'25
Missed
by $0.13
Q3'25
Missed
by $0.11
The last earnings report on August 12 showed earnings per share of -40 cents, beating the estimate of -56 cents. With 202.50K shares outstanding, the current market capitalization sits at 346.48M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a developer of vaccines
Industry Biotechnology
Industry
Biotechnology
Address
225 Franklin Street
Phone
+1 857 284-8891
Employees
55
Web
https://www.ateapharma.com